Clatterbridge Cancer Centre is ready to open for patients in Liverpool, UK on 27 June. The facility is part of a £162m investment meant to expand cancer care in the region.
The Clatterbridge Cancer Centre NHS Foundation Trust will run the hospital, along with its existing sites in Wirral and Aintree and network of clinics in Cheshire and Merseyside.
Clatterbridge Cancer Centre is a 11-storey, 110-bed hospital that will provide specialist cancer care, including chemotherapy, immunotherapy, gene therapy and radiotherapy.
The hospital includes facilities for bone marrow transplant, diagnostics and imaging, outpatients, daycase treatments and clinical therapies, among other cancer information and support.
It is designed to enable personalisation based on patients’ individual needs. All inpatients will be given single en-suite rooms to mitigate infection risk.
The Clatterbridge Cancer Centre NHS Foundation Trust chief executive Dr Liz Bishop said: “Our staff are now making the final preparations for opening on 27 June and we are all very excited about the benefits it will bring for cancer care in Cheshire and Merseyside.
“It is a significant expansion of cancer services, in addition to services at our Wirral and Aintree sites and our network of clinics across the region.”
Laing O’Rourke was the main contractor for the new cancer hospital, while BDP was lead architect and AECOM provided design engineering services.
Laing O’Rourke UK Building director Paul McNerney said: “For Clatterbridge we built the hospital virtually, in a digital model before any on-site work began.
“This meant that we could design large elements of the building to precise specifications, manufacture them off-site and then assemble them on site minimising disruption to neighbours and to the adjacent Royal.”
Construction of the cancer hospital begun in 2017, following initial site work in 2016.